Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use
Clinical Rheumatology · 2026
DOI: 10.1007/s10067-026-08357-8 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Sheng Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, D…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Arthritis, Rheumatoid, Hydroxychloroquine. Die Arbeit nennt 18 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, Jiangxi, 330006, China.
- Department of Rheumatology and Immunology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No.17, Yongwaizheng Street, Donghu District, Nanchang, Jiangxi, 330006, China. ndyfy00400@ncu.edu.c…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, S., Jiang, H., Yan, Y., & Wu, R. (2026). Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08357-8
Vancouver
Zhao S, Jiang H, Yan Y, Wu R. Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-08357-8
BibTeX
@article{Zhao2026,
author = {Zhao, Sheng and Jiang, Houhui and Yan, Yuxin and Wu, Rui},
title = {Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use},
journal = {Clinical Rheumatology},
year = {2026},
doi = {10.1007/s10067-026-08357-8}
}
EUVIMED